🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
601,32 USD
Máx. histórico
601,32
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
430,02 – 609,99
Variación hoy
+0,87%
Cierre anterior
596,13
Rango de hoy
596,14 – 606,16
Volumen hoy
595.233
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,54 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 22 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 21/10/2024 | 366,99 | 372,72 | 362,32 | 370,60 | +0,59% | 2,83% | 312.500 |
| 18/10/2024 | 372,87 | 372,87 | 367,75 | 368,43 | -1,17% | 1,37% | 243.100 |
| 17/10/2024 | 370,00 | 377,03 | 369,15 | 372,81 | +0,77% | 2,13% | 318.500 |
| 16/10/2024 | 359,59 | 374,73 | 359,59 | 369,96 | +2,89% | 4,21% | 603.200 |
| 15/10/2024 | 357,78 | 362,98 | 356,64 | 359,57 | +0,69% | 1,77% | 329.400 |
| 14/10/2024 | 355,88 | 359,01 | 354,70 | 357,10 | -0,31% | 1,21% | 156.300 |
| 11/10/2024 | 355,62 | 358,82 | 354,00 | 358,22 | +1,10% | 1,36% | 160.300 |
| 10/10/2024 | 355,17 | 355,96 | 349,40 | 354,33 | -0,70% | 1,85% | 193.000 |
| 09/10/2024 | 355,79 | 357,24 | 351,76 | 356,81 | +0,29% | 1,54% | 207.500 |
| 08/10/2024 | 351,75 | 357,18 | 351,33 | 355,79 | +1,70% | 1,66% | 226.300 |
| 07/10/2024 | 355,54 | 358,97 | 346,31 | 349,85 | -1,71% | 3,56% | 361.700 |
| 04/10/2024 | 350,07 | 355,95 | 350,07 | 355,93 | +1,67% | 1,68% | 153.700 |
| 03/10/2024 | 352,35 | 357,31 | 348,63 | 350,07 | -0,68% | 2,46% | 229.100 |
| 02/10/2024 | 354,04 | 354,04 | 343,23 | 352,47 | -1,50% | 3,05% | 258.400 |
| 01/10/2024 | 359,34 | 359,34 | 354,25 | 357,83 | -0,15% | 1,42% | 202.400 |
| 30/09/2024 | 358,62 | 360,63 | 352,93 | 358,35 | -0,05% | 2,15% | 271.700 |
| 27/09/2024 | 359,82 | 360,79 | 355,05 | 358,53 | +0,23% | 1,60% | 254.700 |
| 26/09/2024 | 359,85 | 362,52 | 356,79 | 357,72 | -0,50% | 1,59% | 269.700 |
| 25/09/2024 | 358,40 | 361,88 | 355,13 | 359,51 | +0,46% | 1,88% | 430.800 |
| 24/09/2024 | 355,59 | 358,65 | 347,00 | 357,87 | +0,64% | 3,28% | 681.500 |
| 23/09/2024 | 354,04 | 360,00 | 354,00 | 355,59 | +0,73% | 1,69% | 410.000 |
| 20/09/2024 | 349,11 | 354,70 | 349,11 | 353,00 | +0,48% | 1,60% | 900.800 |
| 19/09/2024 | 345,46 | 353,04 | 344,47 | 351,33 | +2,55% | 2,48% | 454.400 |
| 18/09/2024 | 344,57 | 347,57 | 342,03 | 342,59 | -0,70% | 1,61% | 288.100 |
| 17/09/2024 | 341,92 | 353,63 | 341,92 | 345,02 | +0,01% | 3,42% | 427.200 |
| 16/09/2024 | 339,12 | 345,47 | 338,41 | 344,98 | +1,73% | 2,08% | 393.800 |
| 13/09/2024 | 341,69 | 347,29 | 337,52 | 339,12 | -0,58% | 2,86% | 455.700 |
| 12/09/2024 | 345,77 | 345,77 | 340,65 | 341,11 | -1,47% | 1,48% | 384.800 |
| 11/09/2024 | 343,00 | 347,21 | 340,00 | 346,19 | +1,09% | 2,10% | 417.600 |
| 10/09/2024 | 348,10 | 348,10 | 340,46 | 342,46 | -1,79% | 2,19% | 358.100 |